Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.01.17	Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Catalent (PR Newswire)
03.01.17	EQUITY UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN (PR Newswire)
03.01.17	Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants (PR Newswire)
24.12.16	Class Action Lawsuit Filed in the United States District Court for the District of New Jersey Against Allergan plc on Behalf of Shareholders - Lead Plaintiff Deadline Remains January 3, 2017 -- AGN (PR Newswire)
22.12.16	Allergan plc Board of Directors Issues Statement on Company's Social Contract with Patients (PR Newswire)
21.12.16	Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference (PR Newswire)
20.12.16	Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion (PR Newswire)
19.12.16	Salpeter Gitkin, LLP Informing Investors of Allergan plc of Securities Class Action Lawsuits (PR Newswire)
15.12.16	Allergan Announces Civil Resolution Concluding Federal Investigation into Forest Sales & Marketing Practices (PR Newswire)
15.12.16	Aegon Announces Management Changes (PR Newswire)
15.12.16	Aegon Announces Management Changes (PR Newswire)
08.12.16	Allergan Comments on PTAB Decision Regarding Mylan's Petitions for Inter Partes Review (IPR) of RESTASIS® Patents (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
02.12.16	Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab (PR Newswire)
02.12.16	Allergan Provides Update on Accelerated Share Repurchase (ASR) Program (PR Newswire)
02.12.16	Allergan Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation (PR Newswire)
01.12.16	Technical Reports on Generic Drugs Stocks -- Mylan, Horizon Pharma, Allergan, and Catalent (PR Newswire)
28.11.16	Aegon to Appoint Matthew Rider as CFO (PR Newswire)
28.11.16	Aegon to Appoint Matthew Rider as CFO (PR Newswire)
23.11.16	Allergan PLC Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action filed by Firm - AGN (PR Newswire)
22.11.16	Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease (PR Newswire)
22.11.16	Allergan Receives FDA Clearance for the XEN® Gel Stent, a New Surgical Treatment for Refractory Glaucoma (PR Newswire)
21.11.16	FIBRISTAL®, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment (PR Newswire)
19.11.16	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline - AGN (PR Newswire)
01.10.15	Allergan Receives FDA Approval To Market JUVEDERM ULTRA XC For Lip Augmentation (RTTNews)
25.09.15	Allergan Launches Generic Version Of Janssen's Invega In U.S. - Quick Facts (RTTNews)
11.09.15	Allergan : FDA Oks 3 Extended Release Products Equivalent To Mucinex, Mucinex DM (RTTNews)
31.08.15	Allergan Completes Naurex Acquisition - Quick Facts (RTTNews)
25.08.15	Allergan Recalls Specific Lots Of Ophthalmic Products Due To Particulate Matter (RTTNews)
21.08.15	AGN To Face FDA In Q1-2016, DPRX Moves One Step Ahead, RPTP, VRX Open Wallets (RTTNews)
20.08.15	Allergan: FDA Accepts BOTOX Resubmission For Lower Limb Spasticity In Adults (RTTNews)
06.08.15	EARNINGS SUMMARY: Allergan Inc. Income Advances (RTTNews)
28.07.15	Allergan-KYTHERA Deal Gets U.S. Antitrust Approval (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09.02.20		Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal
04.10.19		Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an
04.08.19		Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor
05.05.19		Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse
19.02.18		Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten
22.12.17		Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

09.02.20

Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal

04.10.19

Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an

04.08.19

Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor

05.05.19

Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse

19.02.18

Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten

22.12.17

Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	262.10	3.39 %	K V
Lonza Grp	584.80	2.38 %	K V
Logitech Intl	66.76	1.71 %	K V
Part Grp Hldg	1’114.00	1.41 %	K V
Swisscom	544.00	0.74 %	K V
ABB	45.07	0.04 %	K V
Novartis	90.91	-0.22 %	K V
Zurich Insur Gr	581.00	-0.34 %	K V
Roche Hldg G	257.60	-0.88 %	K V
Kuehne+Nagel Int	177.85	-3.24 %	K V

Allergan Aktie VALOR 28551749 / ISIN IE00BY9D5467

Nachrichten zu Allergan plc

Aktien Top/Flop

Allergan Peer Group Nachrichten

Meistgelesene Nachrichten